Neogen (NEOG)

• Market cap: $1.19B
• 1 day: 3.61%
• 5 days: -2.85%
• 1 month: -1.44%
• 3 months: 3.41%
• 6 months: -41.29%
• Year to date: -54.27%
• 1 year: -67.63%
• 5 years: -85.45%
• 10 years: -73.7%
• Sector: Healthcare
• Industry: Diagnostics & Research

About: Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.

Employees: 1,456

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

18% more repeat investments, than reductions

Existing positions increased: 114 | Existing positions reduced: 97

6% less funds holding

Funds holding: 337 [Q1] → 316 (-21) [Q2]

8.28% less ownership

Funds ownership: 119.08% [Q1] → 110.8% (-8.28%) [Q2]

20% less first-time investments, than exits

New positions opened: 68 | Existing positions closed: 85

49% less capital invested

Capital invested by funds: $2.24B [Q1] → $1.15B (-$1.09B) [Q2]

73% less call options, than puts

Call options by funds: $1.34M | Put options by funds: $4.99M

100% less funds holding in top 10

Funds holding in top 10: 1 [Q1] → 0 (-1) [Q2]

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

• Low target: $10
• Avg. target: $10
• High target: $10

1 analyst rating

• positive: 1 100%
• neutral: 0 0%
• negative: 0 0%

Guggenheim Subbu Nambi

$10

Buy Maintained

30 Jun 2025